The region’s only NCI-designated center
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Our team includes experts such as chief of pediatric hematology and oncology Marcio Malogolowkin, M.D., an international leader in pediatric liver tumors and an authority on adolescent and young adult (AYA) cancers.
UC Davis oncologist and researcher receives local cancer award
UC Davis Comprehensive Cancer Center selected pediatric oncologist and clinical researcher Elysia Alvarez, M.D., M.P.H., as the 2023 Christine and Helen Landgraf Memorial Research Award recipient. Alvarez, an associate professor of clinical pediatrics, received $25,000 to expand her research of disparities in cancer survival outcomes among adolescents and young adults. She has special expertise treating young patients with solid tumors and co-leads the Pediatric, Adolescent, and Young Adult Comprehensive Sarcoma Clinic at the cancer center.
Learning from the largest prospective non-rhabdomyosarcoma soft tissue sarcoma clinical trial
A new analysis, led by Elysia Alvarez, M.D., M.P.H., better defines the clinical features and outcomes of young patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) with regional and distant lymph node (LN) metastases. The analysis of patients comes from the largest prospective clinical trial of pediatric and young adult NRSTS in North America conducted by the Children’s Oncology Group. The researchers findings published in the European Journal of Cancer show that nodal recurrence was uncommon in young NRSTS patients with nodal metastases who received protocol-specified surgery and radiotherapy, documenting the efficacy of this approach for future patients.
